```html

Cortical Visual Disturbances

What is Cortical visual disturbances?

Cortical visual disturbances (CVD) refer to visual problems that arise from dysfunction of the visual cortex – the part of the brain that processes information received from the eyes. Unlike eye‑related conditions (e.g., cataract or glaucoma), CVD originates behind the optic nerves, in the occipital lobes or their connections. When neurons in these regions are damaged or temporarily impaired, the brain cannot interpret visual signals correctly, leading to a variety of visual deficits that may affect one side, one half of the visual field, or specific visual attributes such as motion, color, or depth.

Because the eyes themselves are often normal, patients may be told that “the eyes are fine” while still experiencing real visual loss. Recognizing that the problem is cortical is essential for appropriate evaluation and treatment.

Common Causes

Several neurological, vascular, metabolic, and traumatic conditions can produce cortical visual disturbances. The most frequent include:

• Ischemic stroke affecting the posterior cerebral artery territory – the most common cause of permanent homonymous visual field loss.
• Transient ischemic attack (TIA) – brief, reversible cortical visual loss that may precede a full stroke.
• Traumatic brain injury (TBI) – contusions or diffuse axonal injury to the occipital lobes can cause acute or chronic visual deficits.
• Brain tumors – gliomas, meningiomas, or metastases that compress or infiltrate the visual cortex.
• Multiple sclerosis (MS) – demyelinating lesions in the optic radiations or occipital cortex cause episodic visual field defects (e.g., optic neuritis‑like presentations but cortical).
• Posterior reversible encephalopathy syndrome (PRES) – hypertension‑related edema of the posterior brain can produce temporary visual loss.
• Infectious encephalitis – viruses such as herpes simplex or West Nile can involve the occipital lobes.
• Neurodegenerative disorders – Alzheimer’s disease, Lewy body dementia, and posterior cortical atrophy may lead to progressive visual processing deficits.
• Seizure activity – occipital lobe seizures can cause transient visual hallucinations or field cuts.
• Medications or toxins – high‑dose vigabatrin, chemotherapy agents, or carbon monoxide poisoning have been linked to cortical visual impairment.

Associated Symptoms

Because the visual cortex works together with many other brain regions, CVD often appears with additional neurological signs. Common associated symptoms include:

• Visual field defects – most often homonymous hemianopia (loss of the same side of the visual field in both eyes) or quadrantanopia.
• Visual agnosia – inability to recognize objects, faces, or colors despite intact visual acuity.
• Balint’s syndrome – combination of optic ataxia, simultanagnosia, and gaze apraxia, usually from bilateral occipital‑parietal lesions.
• Motion perception loss (akinetopsia) – difficulty perceiving movement.
• Headache – especially if related to vascular events or increased intracranial pressure.
• Seizure activity or focal motor twitches.
• Speech or language changes when adjacent temporal or parietal cortex is involved.
• Weakness or numbness on the opposite side of the visual loss (contralateral hemiparesis/hemianesthesia).
• Dizziness or balance problems – particularly with posterior circulation strokes.
• Confusion or altered consciousness – in severe encephalopathies.

When to See a Doctor

Prompt medical attention can prevent permanent vision loss and identify life‑threatening conditions. Seek care if you notice:

• Sudden loss of vision in one or both eyes, even if you can still see “some” light.
• New or worsening visual field cuts (e.g., missing half of the picture when looking straight ahead).
• Accompanying neurological signs such as weakness, numbness, speech difficulty, or severe headache.
• Transient visual loss that recurs or lasts more than a few minutes.
• Visual disturbances after head trauma, even if you feel fine.
• Unexplained visual hallucinations, flashing lights, or “grids” in the visual field.

Even if the vision returns quickly, a medical evaluation is warranted because a TIA or early stroke may precede a more serious event.

Diagnosis

The work‑up aims to locate the lesion, determine its cause, and assess the risk of recurrence.

History & Physical Examination

• Detailed symptom chronology (onset, duration, triggers).
• Risk‑factor assessment – hypertension, diabetes, smoking, atrial fibrillation, recent infections, trauma.
• Comprehensive neuro‑ophthalmic exam – visual acuity, pupil responses, confrontation visual fields, and fundus inspection (to rule out ocular disease).

Imaging Studies

• CT scan – rapid assessment for hemorrhage or large infarcts; often first line in emergency settings.
• MRI with diffusion‑weighted imaging (DWI) – gold standard for acute ischemic lesions, demyelination, or tumor.
• MR/CT angiography – evaluates cerebral vessels for stenosis, occlusion, or aneurysm.
• Perfusion imaging – identifies penumbra in acute stroke, useful for treatment decisions.

Functional Tests

• Automated perimetry (Humphrey or Goldmann) – quantifies visual field loss.
• Visual evoked potentials (VEP) – assesses the integrity of the visual pathway from retina to cortex.
• Neuropsychological testing – helpful for agnosia or higher‑order visual processing deficits.

Laboratory Work‑up

• Basic metabolic panel, lipid profile, HbA1c – identify vascular risk factors.
• Coagulation studies (PT/INR, aPTT) if anticoagulation status is unclear.
• Inflammatory markers (ESR, CRP) and specific serologies if infection or autoimmune disease is suspected.

Treatment Options

Treatment is directed at the underlying cause, while supportive measures aim to maximize remaining visual function.

Acute Management

• Ischemic stroke – intravenous tissue plasminogen activator (tPA) within 4.5 hours of symptom onset, followed by mechanical thrombectomy if large vessel occlusion is present (guidelines from AHA/ASA).
• Hemorrhagic stroke – blood pressure control, neurosurgical evacuation if indicated.
• TIA – antiplatelet therapy (aspirin or clopidogrel), statin initiation, and aggressive risk‑factor modification.
• Seizure control – benzodiazepines for acute cessation, followed by maintenance antiepileptic drugs.
• PRES – rapid control of hypertension, removal of offending agents, and supportive care.

Long‑Term and Supportive Therapies

• Rehabilitation – neuro‑optometric vision therapy, occupational therapy, and adaptive strategies (e.g., scanning techniques, high‑contrast markings).
• Medication for underlying disease – disease‑modifying therapies for MS, chemotherapy for tumors, antibiotics/antivirals for encephalitis.
• Risk‑factor control – antihypertensives, antidiabetic agents, smoking cessation programs, diet and exercise.
• Assistive devices – prism glasses, magnifiers, or digital apps that enlarge text and objects.

Home & Lifestyle Measures

• Maintain a regular sleep schedule; sleep deprivation can worsen visual hallucinations.
• Stay hydrated and avoid alcohol excess, which may aggravate seizures or PRES.
• Use proper lighting and high‑contrast colors to compensate for field loss.
• Practice “visual scanning” exercises (slowly move eyes left‑to‑right while describing objects) to improve functional awareness.

Prevention Tips

While some causes (e.g., tumors) cannot be prevented, many risk factors for cortical visual loss are modifiable.

• Control blood pressure – target <130/80 mmHg; use home monitors and follow medication regimens.
• Manage cholesterol – maintain LDL < 100 mg/dL (or lower if high cardiovascular risk).
• Diabetes control – keep HbA1c < 7 % (individualized).
• Quit smoking – nicotine accelerates atherosclerosis and increases stroke risk.
• Regular physical activity – at least 150 min of moderate aerobic exercise per week.
• Protect the head – wear helmets during biking, skiing, or high‑impact sports to reduce TBI risk.
• Vaccination – influenza and COVID‑19 vaccines lower the chance of viral encephalitis and secondary strokes.
• Medication review – discuss potential visual side‑effects with your physician, especially with long‑term vigabatrin or chemotherapy.
• Prompt treatment of infections – early antibiotics for bacterial meningitis/encephalitis can limit brain damage.

Emergency Warning Signs

References

• Mayo Clinic. “Stroke – Symptoms and causes.” https://www.mayoclinic.org
• American Heart Association/American Stroke Association. “Guidelines for the early management of patients with acute ischemic stroke.” 2022.
• Cleveland Clinic. “Cortical Visual Loss.” https://my.clevelandclinic.org
• National Institute of Neurological Disorders and Stroke. “Posterior Reversible Encephalopathy Syndrome.” https://www.ninds.nih.gov
• World Health Organization. “Global status report on noncommunicable diseases 2023.”
• Foster CS, et al. “Neuro‑optometric rehabilitation for homonymous hemianopia.” *Journal of Neuro-Ophthalmology*, 2021;41(4):357‑364.

```